泰利福(TFX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TFX 泰利福

休市中 07-10 16:00:00 EDT

135.73

+1.69

+1.26%

盘后135.73

+0.000.00%

16:10 EDT

最高137.09	最低134.32	成交量52.95万
今开135.57	昨收134.04	日振幅2.07%
总市值59.99亿	流通市值59.76亿	总股本4,419万
成交额7,193万	换手率1.20%	流通股本4,403万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TFX","market":"US","secType":"STK","nameCN":"泰利福","latestPrice":135.73,"timestamp":1783713600000,"preClose":134.04,"halted":0,"volume":529473,"hourTrading":{"tag":"盘后","latestPrice":135.73,"preClose":135.73,"latestTime":"16:10 EDT","volume":101310,"amount":13750803.67,"timestamp":1783714204963,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.012608176663682467,"floatShares":44031659,"shares":44194408,"eps":-22.802416,"marketStatus":"休市中","change":1.69,"latestTime":"07-10 16:00:00 EDT","open":135.57,"high":137.085,"low":134.315,"amount":71934377,"amplitude":0.020665,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-22.802416,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783929600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":134.04,"dividendRate":0.01002,"preHourTrading":{"tag":"盘前","latestPrice":134.5,"preClose":134.04,"latestTime":"09:29 EDT","volume":13,"amount":1748.7499899999998,"timestamp":1783690199165,"change":0.46,"changeRate":0.003432,"amplitude":0.00276},"postHourTrading":{"tag":"盘后","latestPrice":135.73,"preClose":135.73,"latestTime":"16:10 EDT","volume":101310,"amount":13750803.67,"timestamp":1783714204963,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.109599,"impliedVol":0.4439,"impliedVolPercentile":0.6733},"requestUrl":"/m/hq/s/TFX","defaultTab":"news","newsList":[{"id":"1139183059","title":"泰利福启动全球Biomag™‑III关键试验患者招募，评估Freesolve™可吸收镁合金支架","url":"https://stock-news.laohu8.com/highlight/detail?id=1139183059","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139183059?lang=zh_cn&edition=full","pubTime":"2026-06-23 18:31","pubTimestamp":1782210691,"startTime":"0","endTime":"0","summary":"泰利福公司已正式启动其全球性Biomag™‑III关键试验的患者招募工作，该试验旨在评估其创新的Freesolve™可吸收镁合金支架。这一举措标志着该器械的临床开发进入了新的重要阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFX","BK4588","BK4585","BK4082","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155388725","title":"欧洲PCR大会公布Biomag™-I四年研究结果，证实Freesolve™可吸收镁合金支架（Dreams 3G）长期安全性与持续性能","url":"https://stock-news.laohu8.com/highlight/detail?id=1155388725","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155388725?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:30","pubTimestamp":1781001030,"startTime":"0","endTime":"0","summary":"在欧洲PCR大会上公布的Biomag™-I四年期研究数据，有力证实了Freesolve™可吸收镁合金支架（亦称Dreams 3G）具备优异的长期安全性与持续的临床性能。该研究结果标志着这一创新器械在血管介入治疗领域的长期表现获得了关键验证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TFX","BK4504","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186388352","title":"Piper Sandler上调泰利福评级至增持，目标价升至160美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186388352","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186388352?lang=zh_cn&edition=full","pubTime":"2026-06-08 15:36","pubTimestamp":1780904173,"startTime":"0","endTime":"0","summary":"投资机构Piper Sandler将泰利福的股票评级从“中性”上调至“增持”，同时将其目标股价从140美元大幅提升至160美元。这一调整反映了该机构对泰利福未来增长前景的积极看法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4588","BK4585","BK4082","TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122385119","title":"泰利福公司宣布私募发行5亿美元2032年到期优先票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1122385119","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122385119?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:05","pubTimestamp":1780315514,"startTime":"0","endTime":"0","summary":"泰利福公司宣布启动一项私募发行，计划发行总额5亿美元、于2032年到期的优先票据。与此同时，该公司宣布将赎回所有尚未偿还的、于2027年到期、票面利率为4.63%的优先票据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4082","BK4585","BK4504","TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114593256","title":"泰利福：循环信贷与A-1定期贷款将于2031年5月26日到期；A-2定期贷款2028年5月26日到期——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1114593256","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114593256?lang=zh_cn&edition=full","pubTime":"2026-05-28 05:26","pubTimestamp":1779917174,"startTime":"0","endTime":"0","summary":"根据提交至美国证券交易委员会（SEC）的文件显示，医疗设备制造商泰利福（Teleflex）的循环信贷额度与A-1定期贷款将于2031年5月26日到期。与此同时，其A-2定期贷款的到期日则设定在更早的2028年5月26日。这一信息明确了公司部分长期债务的结构与关键时间节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TFX","BK4585","BK4504","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192788863","title":"Irenic Capital敦促泰利福董事会设立战略评估小组委员会 并引入新任独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1192788863","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192788863?lang=zh_cn&edition=full","pubTime":"2026-03-28 02:34","pubTimestamp":1774636456,"startTime":"0","endTime":"0","summary":"激进投资机构Irenic Capital Management日前公开呼吁医疗设备制造商泰利福（Teleflex）董事会采取紧急行动，要求其立即设立专门的战略评估小组委员会。该机构强调，此委员会必须由新委任的独立董事领导，旨在对公司现有战略方向、资产组合及资本配置效率进行全面复核。\nIrenic Capital在声明中指出，当前泰利福的股价表现持续弱于同行及大盘，反映出市场对其战略执行力和增长前景的深切担忧。通过成立由独立董事主导的专项委员会，可确保战略评估过程的客观性与透明度，从而为所有股东探索价值最大化的可行路径，包括但不限于业务拆分、资产出售或运营优化等潜在方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4588","BK4585","BK4082","TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171479146","title":"泰利福启动重组计划，预计2028年中实现每年5000万美元税前成本节约","url":"https://stock-news.laohu8.com/highlight/detail?id=1171479146","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171479146?lang=zh_cn&edition=full","pubTime":"2026-03-28 01:03","pubTimestamp":1774630994,"startTime":"0","endTime":"0","summary":"医疗器械制造商泰利福公司近日公布了一项战略性重组计划。该方案旨在优化公司运营效率，目标是在2028年中期之前，实现每年约5000万美元的税前成本节约。\n此项重组预计将对公司的长期财务健康产生积极影响，通过精简结构和提升运营杠杆来增强盈利能力。公司管理层对此计划充满信心，认为这将为未来的可持续增长奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4504","TFX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193219699","title":"泰利福将动用交易所得，实施10亿美元股票回购并偿还8亿美元债务","url":"https://stock-news.laohu8.com/highlight/detail?id=1193219699","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193219699?lang=zh_cn&edition=full","pubTime":"2026-03-28 01:03","pubTimestamp":1774630993,"startTime":"0","endTime":"0","summary":"医疗器械巨头泰利福公司宣布，计划将近期一系列交易产生的资金用于两项重要的资本配置行动：一项规模高达10亿美元的股票回购计划，以及偿还总额为8亿美元的债务。\n这一战略举措旨在优化公司资本结构，提升股东价值，并通过减少利息支出来增强财务灵活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFX","BK4585","BK4588","BK4504","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141899151","title":"泰利福公司急性护理与泌尿科业务交易预计于2026年下半年完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1141899151","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141899151?lang=zh_cn&edition=full","pubTime":"2026-03-18 04:50","pubTimestamp":1773780614,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）的最新文件披露，医疗器械公司泰利福（Teleflex）已明确其急性护理与泌尿科业务相关交易的时间表。该重大交易预计将在2026年下半年最终完成。\n这一时间节点的明确，为市场参与者提供了清晰的预期。交易涉及的业务板块是泰利福公司战略布局中的重要组成部分，其顺利推进对公司未来的业务结构和增长路径具有深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","TFX","BK4585","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121007871","title":"泰利福旗下急症护理与泌尿科业务收购方收到美国联邦贸易委员会补充信息请求","url":"https://stock-news.laohu8.com/highlight/detail?id=1121007871","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121007871?lang=zh_cn&edition=full","pubTime":"2026-03-18 04:49","pubTimestamp":1773780588,"startTime":"0","endTime":"0","summary":"3月11日，泰利福公司宣布，其急症护理与泌尿科业务收购方已收到美国联邦贸易委员会（FTC）发出的补充信息与文件材料请求。该请求属于监管审查流程的标准环节，旨在进一步评估交易细节。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TFX","BK4585","BK4504","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120460782","title":"异动解读 | 泰利福公布重组计划，股价盘前大跌11.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120460782","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120460782?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:43","pubTimestamp":1772106211,"startTime":"0","endTime":"0","summary":"医疗器械公司泰利福今日盘前股价大跌11.52%，引起了市场的广泛关注。消息面上，泰利福在盘前交易时段宣布了一项重组计划，旨在优化公司运营结构并削减因近期资产剥离所产生的年度闲置成本，金额在4800万至5200万美元之间。该计划的核心目标包括整合全球组织架构与供应链体系，以使公司的运营模式与其未来的战略重点和精简后的业务组合更加匹配。市场分析认为，尽管重组计划旨在提升长期成本效率和业务协同，但投资者可能对重组过程中可能带来的短期不确定性、执行风险以及成本结构变化表示担忧，这或是导致股价在消息公布后应声下跌的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190403827","title":"泰利福公布初步重组计划，旨在削减因资产剥离产生的4800万至5200万美元年度闲置成本","url":"https://stock-news.laohu8.com/highlight/detail?id=1190403827","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190403827?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:35","pubTimestamp":1772105726,"startTime":"0","endTime":"0","summary":"医疗器械公司泰利福宣布了一项初步重组方案，目标为每年减少因近期资产剥离所导致的4800万至5200万美元闲置成本。该计划旨在优化公司运营结构，提升整体成本效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4588","BK4504","BK4585","TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184508860","title":"泰利福公司宣布重组以优化规模并降低与战略剥离相关的成本结构","url":"https://stock-news.laohu8.com/highlight/detail?id=1184508860","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184508860?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:32","pubTimestamp":1772105543,"startTime":"0","endTime":"0","summary":"泰利福公司宣布了一项重组计划，旨在优化其组织规模，并降低与近期公布的战略性资产剥离相关的成本结构。此举是为了使公司的运营模式与其未来的战略重点和精简后的业务组合更加匹配。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4504","BK4082","TFX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107688623","title":"财报前瞻｜泰利福本季度营收预计增13.04%，盈利端或承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1107688623","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107688623?lang=zh_cn&edition=full","pubTime":"2026-02-19 12:30","pubTimestamp":1771475415,"startTime":"0","endTime":"0","summary":"泰利福将于2026年02月26日发布最新季度财报，市场关注营收延续增长与利润修复节奏。市场一致预期显示，本季度泰利福营收预计为9.19亿USD，同比增13.04%；调整后每股收益预计为3.73美元，同比降3.30%，公司层面未见对本季度毛利率与净利润或净利率的一致前瞻披露，故不展示相关预测。结合市场一致预期，本季度营收预计同比增长13.04%，延续上季的较快节奏，核心贡献仍有望来自北美方向的介入与血管相关组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜泰利福本季度营收预计增13.04%，盈利端或承压","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187832241","title":"夜盘异动 | DoorDash涨超5%，公司获纳入标普500指数","url":"https://stock-news.laohu8.com/highlight/detail?id=1187832241","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187832241?lang=zh_cn&edition=full","pubTime":"2025-03-10 10:11","pubTimestamp":1741572704,"startTime":"0","endTime":"0","summary":"3月10日，DoorDash夜盘涨超5%，TKO Group涨近3%。消息方面：标普道琼斯指数公司在一份新闻稿中表示，DoorDash、Williams-Sonoma、Expand Energy和TKO Group将取代Borgwarner、Teleflex、Celanese Corp和FMC Corp加入标普500指数，自3月24日起生效。","market":"us","thumbnail":"https://static.tigerbbs.com/93c3dba7c4b0e443e40fe6df5639434d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/93c3dba7c4b0e443e40fe6df5639434d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFX","SDS",".SPX","ESmain","OEF","BWA","DASH","BK4549","EXE","SH","SPY","BK4505","BK4504","BK4551","BK4548","FMC","BK4559","BK4122","BK4581","BK4585","BK4209","TKO","BK4536","CE","WSM","BK4534","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517162672","title":"泰利福2024财年实现净利润70.16百万美元，同比减少80.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162672?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:01","pubTimestamp":1741276868,"startTime":"0","endTime":"0","summary":"3月7日，泰利福公布财报，公告显示公司2024财年净利润为70.16百万美元，同比减少80.40%；其中营业收入为30.47亿美元，同比增加2.45%，每股基本收益为1.49美元。从资产负债表来看，泰利福总负债28.20亿美元，其中短期债务1.17亿美元，资产负债比为2.52，流动比率为2.27。机构评级：截至2025年3月7日，当前有8家机构对泰利福目标价做出预测，其中目标均价为157.00美元，其中最低目标价为140.00美元，最高目标价为191.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000122abeb8d0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000122abeb8d0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190378018","title":"异动解读 | 泰利福股价盘中大涨5.17%,主要受益于医疗设备需求攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=1190378018","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190378018?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:30","pubTimestamp":1741188626,"startTime":"0","endTime":"0","summary":"泰利福医疗公司今日盘中股价大涨5.17%,引发了市场的广泛关注。\n泰利福是一家提供多元化医疗设备及用品的公司,主要业务覆盖血液/血管、外科、麻醉、介入和原始设备制造等领域。近年来,随着人口老龄化程度加深以及医疗保健需求不断增长,对泰利福产品的需求也随之攀升。\n此外,泰利福在持续的研发创新,不断推出新产品以满足市场需求。分析师普遍认为,泰利福的产品组合优势使其在行业内具有较强竞争力,潜在的增长空间较大,因此对公司的未来发展前景持乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 泰利福股价盘中大涨5.17%,主要受益于医疗设备需求攀升","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517110945","title":"泰利福盘中异动 股价大涨5.17%报137.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517110945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517110945?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:45","pubTimestamp":1741185958,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时45分，泰利福股票出现波动，股价快速拉升5.17%。截至发稿，该股报137.56美元/股，成交量3.3486万股，换手率0.07%，振幅3.96%。泰利福股票所在的医疗设备行业中，整体涨幅为0.11%。其相关个股中，泰利福、Pro-Dex, Inc.、Sanara Medtech Inc.涨幅较大，Sharps Technology Inc.、Glucotrack, Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为1.56%、0.46%、0.40%，振幅较大的相关个股有Retractable Technologies, Inc.、哈佛生物科学、Sharps Technology Inc.，振幅分别为8.43%、7.38%、6.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224558a260cca9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224558a260cca9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4504","BK4082","TFX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130700656","title":"异动解读 | 泰利福(TFX)股价盘中大跌6.11% 机构调低目标价令人失望","url":"https://stock-news.laohu8.com/highlight/detail?id=1130700656","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130700656?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:02","pubTimestamp":1740769353,"startTime":"0","endTime":"0","summary":"医疗设备制造商泰利福(TFX)今日盘中股价大跌6.11%,引发市场关注。导致大跌的主因或与富国银行(WFC)调低了该股评级目标价有关。\n\n富国银行近日维持泰利福评级为\"持股观望\",但将目标价从之前的214美元下调至146美元,相比上日收盘价低了约32%。分析人士认为,机构大幅调低目标价令投资者感到失望,资金出现大规模流出,从而导致该股出现盘中大跌行情。\n\n泰利福公司近期经营状况并无重大变化,去年全年实现营收30.47亿美元,净利7016万美元。投资机构认为目前股价估值水平仍有一定上升空间,但大幅下调目标价反映了对该公司未来发展前景的担忧。投资者或需继续关注公司最新动向,审慎判断投资时机。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 泰利福(TFX)股价盘中大跌6.11% 机构调低目标价令人失望","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516308270","title":"富国银行：维持Teleflex(TFX.US)评级，由持股观望调整至持股观望评级, 目标价由214.00美元调整至146.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308270","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516308270?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:51","pubTimestamp":1740768683,"startTime":"0","endTime":"0","summary":"富国银行：维持Teleflex(TFX.US)评级，由持股观望调整至持股观望评级, 目标价由214.00美元调整至146.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01025148470118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TFX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.teleflex.com","stockEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.1465},{"period":"6month","weight":0.2032},{"period":"1year","weight":0.1316},{"period":"ytd","weight":0.1122}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1111},{"period":"6month","weight":0.0877},{"period":"1year","weight":0.2063},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Teleflex Incorporated是一家特拉华州公司，成立于1943年。该公司是一家医疗技术产品的全球供应商，这些产品可提高临床获益、提高患者和提供者的安全性并降低总程序成本。该公司主要设计、开发、制造和供应用于重症监护和外科应用中常见诊断和治疗程序的医院和医疗保健提供者使用的一次性医疗器械。该公司通过直销队伍和分销商相结合的方式向世界各地的医院和医疗保健供应商营销和销售产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.456522,"avgChangeRate":-0.003698},{"month":2,"riseRate":0.673913,"avgChangeRate":0.026962},{"month":3,"riseRate":0.608696,"avgChangeRate":0.021581},{"month":4,"riseRate":0.595745,"avgChangeRate":0.022507},{"month":5,"riseRate":0.574468,"avgChangeRate":0.009474},{"month":6,"riseRate":0.446809,"avgChangeRate":-0.000317},{"month":7,"riseRate":0.659574,"avgChangeRate":0.028651},{"month":8,"riseRate":0.478261,"avgChangeRate":-0.007448},{"month":9,"riseRate":0.434783,"avgChangeRate":-0.021349},{"month":10,"riseRate":0.543478,"avgChangeRate":-0.001442},{"month":11,"riseRate":0.673913,"avgChangeRate":0.024236},{"month":12,"riseRate":0.673913,"avgChangeRate":0.024353}],"exchange":"NYSE","name":"泰利福","nameEN":"Teleflex"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰利福(TFX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰利福(TFX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰利福,TFX,泰利福股票,泰利福股票老虎,泰利福股票老虎国际,泰利福行情,泰利福股票行情,泰利福股价,泰利福股市,泰利福股票价格,泰利福股票交易,泰利福股票购买,泰利福股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰利福(TFX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰利福(TFX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}